Ensembl ID ENSG00000141367 Gene ID 1213 Accession 2092
Gene Symbol CLTC Alias Hc;CHC;CHC17;MRD56;CLH-17;CLTCL2 Full Name clathrin heavy chain
Position 17 : 59619684 - 59696956 Length 77273 bases Strand Plus strand
Status Confidence Main interacting RNAsN.A.RBP type Non-canonical_RBPs
Summary Clathrin is a major protein component of the cytoplasmic face of intracellular organelles, called coated vesicles and coated pits. These specialized organelles are involved in the intracellular trafficking of receptors and endocytosis of a variety of macromolecules. The basic subunit of the clathrin coat is composed of three heavy chains and three light chains. [provided by RefSeq, Jul 2008]

ENSG00000141367 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000141367 CLTC -0.5 2.53e-19 KIRC
ENSG00000141367 CLTC 0.87 3.00e-23 BRCA
ENSG00000141367 CLTC 0.54 7.46e-18 LUAD
Ensembl ID Gene symbol Cancer types Pubmed ID
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000141367 CLTC inflammatory myofibroblastic tumor gene_fusion 50.0% (17/34) 3 entries
ENSG00000141367 CLTC breast ductal adenocarcinoma missense_variant 7.192% (42/584) 2 entries
ENSG00000141367 CLTC lung adenocarcinoma sequence_alteration 5.076% (67/1320) 4 entries
ENSG00000141367 CLTC anaplastic large cell lymphoma gene_fusion 49.11% (55/112) 5 entries
ENSG00000141367 CLTC lung adenocarcinoma missense_variant 5.076% (67/1320) 5 entries
ENSG00000141367 CLTC breast ductal adenocarcinoma sequence_alteration 7.192% (42/584) 1 entry
ENSG00000141367 CLTC lung adenocarcinoma gene_fusion 5.076% (67/1320) 1 entry
ENSG00000141367 CLTC colorectal adenocarcinoma sequence_alteration 6.678% (76/1138) 3 entries
ENSG00000141367 CLTC colorectal adenocarcinoma missense_variant 6.678% (76/1138) 3 entries
ENSG00000141367 CLTC prostate adenocarcinoma sequence_alteration 2.407% (35/1454) 3 entries
ENSG00000141367 CLTC B-cell neoplasm gene_fusion 20.0% (3/15) 1 entry
ENSG00000141367 CLTC skin carcinoma sequence_alteration 3.846% (4/104) 1 entry
ENSG00000141367 CLTC Breast Carcinoma by Gene Expression Profile missense_variant 15.79% (3/19) 2 entries
ENSG00000141367 CLTC osteosarcoma sequence_alteration 1.724% (2/116) 2 entries
ENSG00000141367 CLTC Gastric Diffuse Large B-Cell Lymphoma gene_fusion 50.0% (2/4) 2 entries
ENSG00000141367 CLTC diffuse large B-cell lymphoma sequence_alteration 4.545% (15/330) 1 entry
ENSG00000141367 CLTC gastric adenocarcinoma missense_variant 2.33% (13/558) 1 entry
ENSG00000141367 CLTC clear cell renal carcinoma missense_variant 0.8708% (12/1378) 1 entry
ENSG00000141367 CLTC chronic lymphocytic leukemia sequence_alteration 1.014% (9/888) 1 entry
ENSG00000141367 CLTC small cell lung carcinoma missense_variant 1.238% (4/323) 2 entries
ENSG00000141367 CLTC esophageal squamous cell carcinoma missense_variant 1.627% (11/676) 5 entries
ENSG00000141367 CLTC esophageal adenocarcinoma sequence_alteration 4.795% (21/438) 1 entry
ENSG00000141367 CLTC bladder transitional cell carcinoma sequence_alteration 4.639% (9/194) 3 entries
ENSG00000141367 CLTC squamous cell lung carcinoma sequence_alteration 3.815% (33/865) 2 entries
ENSG00000141367 CLTC papillary renal cell carcinoma sequence_alteration 1.69% (6/355) 1 entry
ENSG00000141367 CLTC skin melanoma sequence_alteration 1.861% (18/967) 3 entries
ENSG00000141367 CLTC colon adenocarcinoma missense_variant 4.848% (35/722) 4 entries
ENSG00000141367 CLTC esophageal adenocarcinoma missense_variant 4.795% (21/438) 1 entry
ENSG00000141367 CLTC melanoma missense_variant 1.98% (2/101) 2 entries
ENSG00000141367 CLTC hemangioblastoma sequence_alteration 6.25% (2/32) 1 entry
ENSG00000141367 CLTC skin melanoma missense_variant 1.861% (18/967) 3 entries
ENSG00000141367 CLTC hepatocellular carcinoma missense_variant 1.996% (18/902) 2 entries
ENSG00000141367 CLTC renal carcinoma gene_fusion 18.18% (2/11) 2 entries
ENSG00000141367 CLTC gastric intestinal type adenocarcinoma missense_variant 3.529% (3/85) 1 entry
ENSG00000141367 CLTC brain glioblastoma sequence_alteration 0.9719% (9/926) 2 entries
ENSG00000141367 CLTC gastric intestinal type adenocarcinoma sequence_alteration 3.529% (3/85) 1 entry
ENSG00000141367 CLTC esophageal squamous cell carcinoma sequence_alteration 1.627% (11/676) 3 entries
ENSG00000141367 CLTC melanoma sequence_alteration 1.98% (2/101) 2 entries
ENSG00000141367 CLTC basal cell carcinoma sequence_alteration 8.621% (5/58) 1 entry
ENSG00000141367 CLTC bladder transitional cell carcinoma missense_variant 4.639% (9/194) 2 entries
ENSG00000141367 CLTC neoplasm of mature B-cells sequence_alteration 5.882% (2/34) 2 entries
ENSG00000141367 CLTC adenosquamous lung carcinoma gene_fusion 17.65% (3/17) 1 entry
ENSG00000141367 CLTC squamous cell lung carcinoma gene_fusion 3.815% (33/865) 1 entry
ENSG00000141367 CLTC ovarian serous adenocarcinoma missense_variant 0.2972% (2/673) 1 entry
ENSG00000141367 CLTC diffuse large B-cell lymphoma gene_fusion 4.545% (15/330) 6 entries
ENSG00000141367 CLTC rectal adenocarcinoma missense_variant 1.81% (4/221) 1 entry
ENSG00000141367 CLTC colon adenocarcinoma frameshift_variant 4.848% (35/722) 2 entries
ENSG00000141367 CLTC large cell lung carcinoma gene_fusion 19.23% (5/26) 1 entry
ENSG00000141367 CLTC Ampulla of Vater Carcinoma missense_variant 1.015% (2/197) 1 entry
ENSG00000141367 CLTC prostate carcinoma missense_variant 3.093% (15/485) 2 entries
ENSG00000141367 CLTC basal cell carcinoma missense_variant 8.621% (5/58) 1 entry
ENSG00000141367 CLTC small cell lung carcinoma sequence_alteration 1.238% (4/323) 2 entries
ENSG00000141367 CLTC prostate carcinoma sequence_alteration 3.093% (15/485) 2 entries
ENSG00000141367 CLTC papillary renal cell carcinoma missense_variant 1.69% (6/355) 1 entry
ENSG00000141367 CLTC prostate adenocarcinoma missense_variant 2.407% (35/1454) 2 entries
ENSG00000141367 CLTC hepatocellular carcinoma sequence_alteration 1.996% (18/902) 2 entries
ENSG00000141367 CLTC colorectal adenocarcinoma conservative_inframe_deletion 6.678% (76/1138) 1 entry
ENSG00000141367 CLTC clear cell renal carcinoma sequence_alteration 0.8708% (12/1378) 2 entries
ENSG00000141367 CLTC Bladder Inflammatory Myofibroblastic Tumor gene_fusion 50.0% (2/4) 2 entries
ENSG00000141367 CLTC cecum adenocarcinoma sequence_alteration 5.6% (7/125) 1 entry
ENSG00000141367 CLTC HER2 Positive Breast Carcinoma missense_variant 8.861% (14/158) 2 entries
ENSG00000141367 CLTC female breast carcinoma sequence_alteration 1.535% (6/391) 1 entry
ENSG00000141367 CLTC squamous cell lung carcinoma missense_variant 3.815% (33/865) 2 entries
ENSG00000141367 CLTC colon adenocarcinoma sequence_alteration 4.848% (35/722) 7 entries
ENSG00000141367 CLTC dedifferentiated chondrosarcoma sequence_alteration 15.38% (2/13) 1 entry
ENSG00000141367 CLTC HER2 Positive Breast Carcinoma sequence_alteration 8.861% (14/158) 2 entries
ENSG00000141367 CLTC bladder transitional cell carcinoma frameshift_variant 4.639% (9/194) 2 entries
ENSG00000141367 CLTC neoplasm of mature B-cells missense_variant 5.882% (2/34) 2 entries
ENSG00000141367 CLTC cecum adenocarcinoma stop_gained 5.6% (7/125) 1 entry
ENSG00000141367 CLTC cecum adenocarcinoma missense_variant 5.6% (7/125) 2 entries
ENSG00000141367 CLTC Ampulla of Vater Carcinoma sequence_alteration 1.015% (2/197) 1 entry
ENSG00000141367 CLTC alveolar rhabdomyosarcoma missense_variant 1.695% (1/59) 1 entry
ENSG00000141367 CLTC head and neck squamous cell carcinoma missense_variant 0.1597% (1/626) 1 entry
ENSG00000141367 CLTC large cell lung carcinoma sequence_alteration 19.23% (5/26) 1 entry
ENSG00000141367 CLTC skin carcinoma missense_variant 3.846% (4/104) 1 entry
ENSG00000141367 CLTC Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions gene_fusion 50.0% (1/2) 1 entry
ENSG00000141367 CLTC B-cell non-Hodgkins lymphoma gene_fusion 50.0% (1/2) 1 entry
ENSG00000141367 CLTC prostate carcinoma stop_gained 3.093% (15/485) 1 entry
ENSG00000141367 CLTC ovarian carcinoma missense_variant 16.67% (1/6) 1 entry
ENSG00000141367 CLTC renal cell carcinoma sequence_alteration 9.091% (1/11) 1 entry
ENSG00000141367 CLTC Parathyroid Gland Carcinoma sequence_alteration 5.263% (1/19) 1 entry
ENSG00000141367 CLTC polycythemia vera sequence_alteration 2.083% (1/48) 1 entry
ENSG00000141367 CLTC T-cell acute lymphoblastic leukemia missense_variant 0.3367% (2/594) 1 entry
ENSG00000141367 CLTC medullary thyroid gland carcinoma sequence_alteration 5.263% (1/19) 1 entry
ENSG00000141367 CLTC chromophobe renal cell carcinoma frameshift_variant 0.8696% (1/115) 1 entry
ENSG00000141367 CLTC bile duct adenocarcinoma missense_variant 0.5291% (1/189) 1 entry
ENSG00000141367 CLTC Merkel cell skin cancer sequence_alteration 3.333% (1/30) 1 entry
ENSG00000141367 CLTC large cell lung carcinoma missense_variant 19.23% (5/26) 1 entry
ENSG00000141367 CLTC diffuse large B-cell lymphoma missense_variant 4.545% (15/330) 1 entry
ENSG00000141367 CLTC chondroblastoma sequence_alteration 16.67% (1/6) 1 entry
ENSG00000141367 CLTC bladder transitional cell carcinoma stop_gained 4.639% (9/194) 1 entry
ENSG00000141367 CLTC angiosarcoma sequence_alteration 7.692% (1/13) 1 entry
ENSG00000141367 CLTC diffuse gastric adenocarcinoma sequence_alteration 1.266% (1/79) 1 entry
ENSG00000141367 CLTC small intestinal adenocarcinoma sequence_alteration 100.0% (1/1) 1 entry
ENSG00000141367 CLTC medullary thyroid gland carcinoma stop_gained 5.263% (1/19) 1 entry
ENSG00000141367 CLTC metaplastic breast carcinoma missense_variant 1.961% (1/51) 1 entry
ENSG00000141367 CLTC osteosarcoma missense_variant 1.724% (2/116) 1 entry
ENSG00000141367 CLTC chronic myelomonocytic leukemia missense_variant 1.053% (1/95) 1 entry
ENSG00000141367 CLTC dedifferentiated chondrosarcoma missense_variant 15.38% (2/13) 1 entry
ENSG00000141367 CLTC Lung Inflammatory Myofibroblastic Tumor gene_fusion 50.0% (1/2) 1 entry
ENSG00000141367 CLTC T-cell acute lymphoblastic leukemia stop_gained 0.3367% (2/594) 1 entry
ENSG00000141367 CLTC nasopharyngeal squamous cell carcinoma sequence_alteration 0.5988% (1/167) 1 entry
ENSG00000141367 CLTC renal cell carcinoma missense_variant 9.091% (1/11) 1 entry
ENSG00000141367 CLTC bile duct adenocarcinoma sequence_alteration 0.5291% (1/189) 1 entry
ENSG00000141367 CLTC pulmonary mucoepidermoid carcinoma missense_variant 50.0% (1/2) 1 entry
ENSG00000141367 CLTC basal cell carcinoma stop_gained 8.621% (5/58) 1 entry
ENSG00000141367 CLTC chromophobe renal cell carcinoma sequence_alteration 0.8696% (1/115) 1 entry
ENSG00000141367 CLTC female breast carcinoma missense_variant 1.535% (6/391) 1 entry
ENSG00000141367 CLTC Parathyroid Gland Carcinoma missense_variant 5.263% (1/19) 1 entry
ENSG00000141367 CLTC chronic myelomonocytic leukemia sequence_alteration 1.053% (1/95) 1 entry
ENSG00000141367 CLTC T-cell acute lymphoblastic leukemia sequence_alteration 0.3367% (2/594) 1 entry
ENSG00000141367 CLTC Liver Inflammatory Myofibroblastic Tumor gene_fusion 50.0% (1/2) 1 entry
ENSG00000141367 CLTC female breast carcinoma stop_gained 1.535% (6/391) 1 entry
ENSG00000141367 CLTC Small Intestinal Diffuse Large B-Cell Lymphoma gene_fusion 50.0% (1/2) 1 entry
ENSG00000141367 CLTC osteosarcoma frameshift_variant 1.724% (2/116) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000141367 CLTC MESO 0.015 high
ENSG00000141367 CLTC UVM 0.0019 high
ENSG00000141367 CLTC PAAD 0.038 high
ENSG00000141367 CLTC LGG 0.045 high
ENSG00000141367 CLTC HNSC 0.006 high
ENSG00000141367 CLTC READ 0.023 low
ENSG00000141367 CLTC KIRP 0.047 low
ENSG00000141367 CLTC KICH 0.00034 high
ENSG00000141367 CLTC PCPG 0.042 high
ENSG00000141367 CLTC COAD 0.0035 low
ENSG00000141367 CLTC BLCA 0.00021 high
ENSG00000141367 CLTC GBM 0.041 high
ENSG00000141367 CLTC SKCM 0.0063 low
ENSG00000141367 CLTC CESC 0.00064 high
ENSG00000141367 CLTC LIHC 0.00089 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000141367 CLTC LUAD Amp 0.703978 0.116919 0.386060 0.467054
ENSG00000141367 CLTC LGG Amp 1.826458 0.060525 0.553682 0.072125
ENSG00000141367 CLTC KIRP Amp 0.627742 0.050882 0.711537 0.690972
ENSG00000141367 CLTC COAD Amp 0.909240 0.071750 0.522433 0.221729
ENSG00000141367 CLTC PAAD Del 7.057907 0.140038 0.380909 0.255435
ENSG00000141367 CLTC SKCM Amp 4.102378 0.220187 0.544747 0.326975
ENSG00000141367 CLTC LIHC Amp 5.991687 0.224668 0.687652 0.345946
ENSG00000141367 CLTC BLCA Amp 2.794059 0.233532 0.519788 0.448529
ENSG00000141367 CLTC BRCA Amp 76.368655 0.696896 1.006897 0.382407
ENSG00000141367 CLTC UVM Amp 0.721460 0.165534 0.811066 0.162500